Amsterdam Daily News
SEE OTHER BRANDS

The most trusted news from the Netherlands

Amsterdam Daily News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Amsterdam Daily News.

Press releases published on June 27, 2025

Zero Emission Vehicle Market Poised for 21.1% Growth, Reaching USD 1,201.76 Billion by 2031 | AMR

Zero Emission Vehicle Market Poised for 21.1% Growth, Reaching USD 1,201.76 Billion by 2031 | AMR

WILMINGTON, NEW CASTLE, DE, UNITED STATES, June 27, 2025 /⁨EINPresswire.com⁩/ -- According to a new report published by Allied Market Research, titled, “Zero Emission Vehicle Market," The zero emission vehicle market was valued at $182.83 billion in 2021, …

Zamnesia Launches Seeds for Change to Support Beloved Asheville

Zamnesia Launches Seeds for Change to Support Beloved Asheville

ASHEVILLE, NC, UNITED STATES, June 27, 2025 /⁨EINPresswire.com⁩/ -- Zamnesia, a trusted leader in premium cannabis genetics and culture, is proud to announce the launch of Seeds for Change, a philanthropic initiative dedicated to raising funds for Beloved …

Resonac and PulseForge Unite to Advance Photonic Debonding for Next-Gen Semiconductor Packaging

Resonac and PulseForge Unite to Advance Photonic Debonding for Next-Gen Semiconductor Packaging

AUSTIN, TX, UNITED STATES, June 26, 2025 /⁨EINPresswire.com⁩/ -- Resonac Corporation and PulseForge, Inc. are pleased to announce a strategic partnership to advance and promote photonic debonding technology for next-generation semiconductor packaging as of …

Pharvaris Announces Clinical Trial Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2025 US HAEA National Summit

Pharvaris Announces Clinical Trial Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2025 US HAEA National Summit

ZUG, Switzerland, June 27, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service